EVIDENT amplía su cartera de soluciones de patología digital Pramana
-EVIDENT amplía su cartera de soluciones de patología digital Pramana para dar soporte a laboratorios de pequeño y mediano tamaño…
Category: Press Releases
EVIDENT étend son portefeuille de solutions de pathologie numérique Pramana pour soutenir les laboratoires de petite et moyenne taille
Le nouveau scanner WSI de table Pramana™ POD offre une imagerie autonome pour aider les laboratoires à créer des images…
EVIDENT erweitert sein Pramana-Portfolio für digitale Pathologie, um kleine und mittelständische Labore zu unterstützen.
Der neue Pramana™ POD Tisch-WSI-Scanner ermöglicht autonomes Imaging und hilft Laboren so, mit minimalem Bedienereingriff pathologenfertige Ganzpräparatbilder zu erstellen. , /PRNewswire/…
Masimo’s smartSET™ FDA Clearance Offers Breakthrough Innovation in Pulse Oximetry to Help Improve Critical Patient Outcomes
Industry-Leading Pulse Oximetry Platform Now Features First-of-Its-Kind Atrial Fibrillation (AFib) Detection with Previously Cleared AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection…
Vivacta Bio and Grit Bio Announce FDA Orphan Drug Designation for In Vivo CAR-T Therapy GT801 in Autoimmune Hemolytic Anemia
, /PRNewswire/ — Vivacta Biotechnology (Shanghai) Co., Ltd. (“Vivacta Bio”), a company spun out of the in vivo CAR-T platform…
SKYRIZI® (risankizumab) and RINVOQ® (upadacitinib) Data Highlight Long-Term Clinical and Endoscopic Outcomes Across Inflammatory Bowel Disease (IBD) at UEGW 2026
20 scientific presentations underscore the breadth of AbbVie’s leadership in Inflammatory Bowel Disease (IBD) research programs Latest long-term and real-world…
EVIDENT Expands Its Pramana Digital Pathology Portfolio to Support Small and Medium-Sized Labs
The new Pramana™ POD benchtop WSI scanner delivers autonomous imaging to help laboratories create pathologist-ready whole slide images with minimal…
AMCP Market Insights Findings Show Uncertainty in Biomarker Testing for ESR1-Mutated Advanced Breast Cancer as Payers Weigh Earlier Detection and a Growing Class of Targeted Therapies
, /PRNewswire/ — Breast cancer is the most common cancer diagnosed in U.S. women. In hormone receptor positive, HER2 negative…
Actinium Pharmaceuticals Announces Inducement Grants to New Employees
, /PRNewswire/ — Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (“Actinium” or the “Company”), a pioneer in the development of targeted radiotherapies,…
Viatris Receives U.S. FDA Approval for RYZUMVI® for the Treatment of Presbyopia
, /PRNewswire/ — Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA)…